Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer (vol 9, e002100, 2021)

被引：0
|
作者：
Wang, H.
Ma, H.
Sove, R. J.
机构：
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷 / 10期
关键词：
D O I：
10.1136/jitc-2020-002100corr1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer
    Wang, Hanwen
    Ma, Huilin
    Sove, Richard J.
    Emens, Leisha A.
    Popel, Aleksander S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (02)
  • [2] Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
    O'Sullivan, Hazel
    Collins, Dearbhaile
    O'Reilly, Seamus
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (10): : 986 - 986
  • [3] Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
    Schmid, P.
    Adams, S.
    Rugo, H. S.
    Schneeweiss, A.
    Barrios, C. H.
    Iwata, H.
    Dieras, V.
    Hegg, R.
    Im, S. -A.
    Wright, G. Shaw
    Henschel, V.
    Molinero, L.
    Chui, S. Y.
    Funke, R.
    Husain, A.
    Winer, E. P.
    Loi, S.
    Emens, L. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2108 - 2121
  • [4] Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer REPLY
    Schmid, Peter
    Chui, Stephen Y.
    Emens, Leisha A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (10): : 987 - 988
  • [5] Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer
    Kang, Connie
    Syed, Yahiya Y.
    DRUGS, 2020, 80 (06) : 601 - 607
  • [6] Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer
    Connie Kang
    Yahiya Y. Syed
    Drugs, 2020, 80 : 601 - 607
  • [7] PHARMACOECONOMIC ANALYSIS OF ATEZOLIZUMAB PLUS NAB-PACLITAXEL IN THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
    Kolbin, A.
    Velum, I
    Balykina, Y.
    Proskurin, M.
    VALUE IN HEALTH, 2019, 22 : S510 - S510
  • [8] IMpassion130: Atezolizumab and nab-Paclitaxel Combination in Patients with triple-negative Breast Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (10) : 1076 - +
  • [9] Cost-effectiveness of combined atezolizumab/nab-paclitaxel for advanced triple-negative breast cancer.
    Salans, Mia A.
    Cherry, Daniel R.
    Yip, Anthony T.
    Courtney, Patrick T.
    Kumar, Abhishek
    Murphy, James Don
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] IN SILICO VIRTUAL CLINICAL TRIALS OF ATEZOLIZUMAB AND NAB-PACLITAXEL IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER.
    Wang, H.
    Ma, H.
    Sove, R.
    Emens, L.
    Popel, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S23 - S23
12345